Coherentmarketinsightsus

  Artificial Blood is really a revolutionary idea of blood transfusion treatment, where specifically engineered compounds perform the basic task of transportation and delivery of vital oxygen to your body instead for that of allogenic blood. The engineered blood contains gapped or'spike'vesicles or capillaries in its blood platelets that enable the blood to circulate in the torso more efficiently. It also includes anticoagulant properties that keep consitently the blood thin such that it delivers oxygen to the blood cells. The new technology of artificial blood has come at the same time when there is lots of concern within the risks of numerous blood-borne diseases because of the increased number of HIV patients and other blood borne infections. Many in the medical field are recommending this alternative to blood transfusion or even to surgery for individuals who are allergic to blood and are therefore unable to receive blood from the sick. This Artificial Blood ...

Artificial blood are synthetic substitutes of biological blood likely to harness a fresh horizon in transfusion medicine. These products are thought as replacement for red blood cells and act to serve few key functions of biological blood, such as acting as transportation medium for oxygen and co2 across the body cells. They could be made by chemical isolation or using recombinant biochemical technology. Although there are numerous products in advanced stages of clinical trials, the commercialization of artificial blood continues to be slow. The key concerns that marketers are addressing are safety, compatibility, and effectiveness of artificial blood. Furthermore, the escalation in how many cases of road accidents, medical interventions, trauma cases, military wars, a smaller number of blood donors available and increase prevalence of blood disorders are the main factors driving the marketplace growth. However, limited shelf life and instability of artificial blood and ...